The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTempleton Emerging Markets Regulatory News (TEM)

Share Price Information for Templeton Emerging Markets (TEM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 159.60
Bid: 159.60
Ask: 159.80
Change: 0.00 (0.00%)
Spread: 0.20 (0.125%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 159.60
TEM Live PriceLast checked at -
Templeton Emerging Markets is an Investment Trust

To provide long-term capital appreciation for private and institutional investors seeking exposure to global emerging markets, supported by both strong customer service and corporate governance.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Templeton Emerging Markets Investment Trust review

7 Aug 2023 07:15

RNS Number : 3705I
Templeton Emerging Markets IT PLC
07 August 2023
 

London, UK, 7 August 2023

Edison issues review on Templeton Emerging Markets Investment Trust (TEM)

Templeton Emerging Markets Investment Trust (TEMIT) benefits from the extensive experience of co-managers Chetan Sehgal (lead manager) and Andrew Ness. The trust's performance has turned a corner as its results tend to be better during periods when share prices are driven by company fundamentals, which are the driver of long-term equity returns, rather than macroeconomic factors. Emerging markets offer a broad range of investment opportunities and are home to a growing number of world-class, leading businesses. While all portfolio stocks are selected on a bottom-up basis, TEMIT's high-conviction portfolio is widely diversified by geography, sector and market cap. Its balanced structure means the fund has potential to outperform in both up and down markets.

 

The trust is the largest fund in the AIC Global Emerging Markets sector by a wide margin and its shares are liquid. TEMIT's 12.8% discount is wider than its historical average of c 11.5% over the last decade, providing scope for a higher valuation if investor risk aversion moderates or if the trust's relative performance continues to improve versus its benchmark and its peers.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first company in-market 17 years ago, Edison has more than 100 employees and covers every economic sector. Headquartered in London, Edison also has offices in New York, Sydney and Wellington.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEANPLEDSDEEA
Date   Source Headline
3rd May 20248:45 amRNSNet Asset Value(s)
2nd May 20249:28 amRNSNet Asset Value(s)
1st May 202410:18 amRNSNet Asset Value(s)
1st May 20249:37 amRNSTotal Voting Rights
30th Apr 20249:05 amRNSNet Asset Value(s)
29th Apr 20244:57 pmRNSTransaction in Own Shares
29th Apr 202410:11 amRNSNet Asset Value(s)
26th Apr 20244:59 pmRNSTransaction in Own Shares
26th Apr 20248:38 amRNSNet Asset Value(s)
25th Apr 20248:52 amRNSNet Asset Value(s)
24th Apr 20244:58 pmRNSTransaction in Own Shares
24th Apr 20248:40 amRNSNet Asset Value(s)
23rd Apr 20244:58 pmRNSTransaction in Own Shares
23rd Apr 20249:27 amRNSNet Asset Value(s)
22nd Apr 20245:02 pmRNSTransaction in Own Shares
22nd Apr 202410:08 amRNSPortfolio Update
22nd Apr 20248:46 amRNSNet Asset Value(s)
19th Apr 20244:57 pmRNSTransaction in Own Shares
19th Apr 20248:48 amRNSNet Asset Value(s)
18th Apr 20244:46 pmRNSTransaction in Own Shares
18th Apr 20248:55 amRNSNet Asset Value(s)
17th Apr 20244:52 pmRNSTransaction in Own Shares
17th Apr 20249:03 amRNSNet Asset Value(s)
16th Apr 20245:05 pmRNSTransaction in Own Shares
16th Apr 20248:36 amRNSNet Asset Value(s)
15th Apr 20244:54 pmRNSTransaction in Own Shares
15th Apr 20249:00 amRNSNet Asset Value(s)
12th Apr 20244:51 pmRNSTransaction in Own Shares
12th Apr 20249:06 amRNSNet Asset Value(s)
11th Apr 20244:54 pmRNSTransaction in Own Shares
11th Apr 20248:43 amRNSNet Asset Value(s)
10th Apr 20244:53 pmRNSTransaction in Own Shares
10th Apr 20248:52 amRNSNet Asset Value(s)
9th Apr 20245:02 pmRNSTransaction in Own Shares
9th Apr 20248:52 amRNSNet Asset Value(s)
8th Apr 20244:53 pmRNSTransaction in Own Shares
8th Apr 20248:49 amRNSNet Asset Value(s)
5th Apr 20248:46 amRNSNet Asset Value(s)
4th Apr 20248:43 amRNSNet Asset Value(s)
3rd Apr 20244:13 pmRNSHolding(s) in Company
3rd Apr 20249:15 amRNSNet Asset Value(s)
2nd Apr 20245:00 pmRNSTransaction in Own Shares
2nd Apr 202410:40 amRNSNet Asset Value(s)
2nd Apr 20249:16 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSNet Asset Value(s)
28th Mar 20249:11 amRNSNet Asset Value(s)
27th Mar 20245:01 pmRNSTransaction in Own Shares
27th Mar 20249:04 amRNSNet Asset Value(s)
26th Mar 20245:03 pmRNSTransaction in Own Shares
26th Mar 20249:10 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.